NSG 533 EXAM 3 (WILKES) NEWEST 2026 ACTUAL
EXAM| NSG533 ADVANCED PHARMACOLOGY EXAM
3 REVIEW WITH COMPLETE REAL EXAM QUESTIONS
AND CORRECT VERIFIED ANSWERS/ ALREADY
GRADED A+ (MOST RECENT!!)
1. A patient reports daytime asthma symptoms three times per
week and nighttime awakenings due to asthma once per
week. How would you classify this patient's asthma control?
A) Well-controlled
B) Not well-controlled
C) Very poorly controlled
D) Intermittent
Correct Answer: B
Rationale: Uncontrolled asthma symptoms include daytime
symptoms more than 2 times per week, nighttime awakenings,
reliever therapy use more than 2 times per week, and activity
intolerance. This patient meets the criteria for not well-controlled
asthma and requires treatment step-up or reassessment.
1
,2. Which of the following medication regimens is appropriate
for a patient with asthma symptoms occurring less than 2
times per month?
A) Daily low-dose ICS with as-needed SABA
B) Daily medium-dose ICS-formoterol
C) As-needed low-dose ICS-formoterol OR as-needed low-dose
ICS with SABA
D) Daily high-dose ICS with LABA
Correct Answer: C
Rationale: Intermittent asthma symptoms (less than 2 times per
month) can be managed with as-needed controller medication to
reduce inflammation and prevent exacerbations. Formoterol is a
fast-acting LABA suitable for reliever use when combined with an
ICS.
3. A patient reports using their rescue inhaler 3-4 times per
week for asthma symptoms. What is the recommended
treatment approach?
A) Daily low-dose ICS and as-needed SABA
B) As-needed SABA only
2
,C) Daily oral corticosteroids
D) Leukotriene receptor antagonist monotherapy
Correct Answer: A
Rationale: More frequent symptoms (more than 2 times per
week) require daily anti-inflammatory control with an ICS. SABAs
provide symptom relief. An alternative is as-needed low-dose
ICS-formoterol, which simplifies the regimen.
4. A patient with severe asthma has daily symptoms. Which
treatment regimen is most appropriate?
A) Daily low-dose ICS with as-needed SABA
B) Daily medium-dose ICS-formoterol with reliever therapy
C) As-needed SABA only
D) Daily oral corticosteroid monotherapy
Correct Answer: B
Rationale: Severe asthma requires higher anti-inflammatory
doses combined with fast-acting bronchodilators. Daily medium-
dose ICS-formoterol or daily high-dose ICS with reliever therapy
is indicated for patients with daily symptoms.
3
, 5. Which of the following is a long-acting beta-agonist (LABA)
used in asthma management?
A) Albuterol
B) Ipratropium bromide
C) Salmeterol
D) Montelukast
Correct Answer: C
Rationale: LABAs include salmeterol, formoterol, and vilanterol.
These are long-acting bronchodilators used in combination with
ICS for asthma control. Albuterol is a SABA, ipratropium is a
SAMA, and montelukast is a leukotriene receptor antagonist.
6. Which medication is a long-acting muscarinic antagonist
(LAMA) used in asthma and COPD?
A) Albuterol
B) Tiotropium bromide
C) Fluticasone
D) Prednisone
Correct Answer: B
4
EXAM| NSG533 ADVANCED PHARMACOLOGY EXAM
3 REVIEW WITH COMPLETE REAL EXAM QUESTIONS
AND CORRECT VERIFIED ANSWERS/ ALREADY
GRADED A+ (MOST RECENT!!)
1. A patient reports daytime asthma symptoms three times per
week and nighttime awakenings due to asthma once per
week. How would you classify this patient's asthma control?
A) Well-controlled
B) Not well-controlled
C) Very poorly controlled
D) Intermittent
Correct Answer: B
Rationale: Uncontrolled asthma symptoms include daytime
symptoms more than 2 times per week, nighttime awakenings,
reliever therapy use more than 2 times per week, and activity
intolerance. This patient meets the criteria for not well-controlled
asthma and requires treatment step-up or reassessment.
1
,2. Which of the following medication regimens is appropriate
for a patient with asthma symptoms occurring less than 2
times per month?
A) Daily low-dose ICS with as-needed SABA
B) Daily medium-dose ICS-formoterol
C) As-needed low-dose ICS-formoterol OR as-needed low-dose
ICS with SABA
D) Daily high-dose ICS with LABA
Correct Answer: C
Rationale: Intermittent asthma symptoms (less than 2 times per
month) can be managed with as-needed controller medication to
reduce inflammation and prevent exacerbations. Formoterol is a
fast-acting LABA suitable for reliever use when combined with an
ICS.
3. A patient reports using their rescue inhaler 3-4 times per
week for asthma symptoms. What is the recommended
treatment approach?
A) Daily low-dose ICS and as-needed SABA
B) As-needed SABA only
2
,C) Daily oral corticosteroids
D) Leukotriene receptor antagonist monotherapy
Correct Answer: A
Rationale: More frequent symptoms (more than 2 times per
week) require daily anti-inflammatory control with an ICS. SABAs
provide symptom relief. An alternative is as-needed low-dose
ICS-formoterol, which simplifies the regimen.
4. A patient with severe asthma has daily symptoms. Which
treatment regimen is most appropriate?
A) Daily low-dose ICS with as-needed SABA
B) Daily medium-dose ICS-formoterol with reliever therapy
C) As-needed SABA only
D) Daily oral corticosteroid monotherapy
Correct Answer: B
Rationale: Severe asthma requires higher anti-inflammatory
doses combined with fast-acting bronchodilators. Daily medium-
dose ICS-formoterol or daily high-dose ICS with reliever therapy
is indicated for patients with daily symptoms.
3
, 5. Which of the following is a long-acting beta-agonist (LABA)
used in asthma management?
A) Albuterol
B) Ipratropium bromide
C) Salmeterol
D) Montelukast
Correct Answer: C
Rationale: LABAs include salmeterol, formoterol, and vilanterol.
These are long-acting bronchodilators used in combination with
ICS for asthma control. Albuterol is a SABA, ipratropium is a
SAMA, and montelukast is a leukotriene receptor antagonist.
6. Which medication is a long-acting muscarinic antagonist
(LAMA) used in asthma and COPD?
A) Albuterol
B) Tiotropium bromide
C) Fluticasone
D) Prednisone
Correct Answer: B
4
